Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hibiscus sabdariffa extract + collagen is a combination nutraceutical product primarily marketed for skin health, anti-aging, and metabolic wellness. *Hibiscus sabdariffa*, also known as Roselle, is a botanical extract rich in anthocyanins, flavonoids, and organic acids (such as hibiscus acid) that exhibit potent antioxidant and anti-inflammatory properties. These components help protect skin cells from oxidative stress and may provide mild antihypertensive effects through the inhibition of angiotensin-converting enzyme (ACE). Collagen, typically included in hydrolyzed form, provides essential amino acids and bioactive peptides that support the structural integrity of the extracellular matrix in skin, hair, nails, and joints. Together, the combination aims to reduce oxidative damage to skin tissues while promoting the synthesis of endogenous collagen fibers to improve skin elasticity, hydration, and overall appearance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on hibiscus sabdariffa extract + collagen.